DAIHAN Scientific Co. Ltd (131220) — Cash Flow-to-Debt Ratio
DAIHAN Scientific Co. Ltd (131220) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of ₩361.12 Million could theoretically repay 0% of its total liabilities (₩13.84 Billion) in one year. See financial agility of DAIHAN Scientific Co. Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
DAIHAN Scientific Co. Ltd Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for DAIHAN Scientific Co. Ltd across 12 annual periods. For the full cash flow conversion analysis, see DAIHAN Scientific Co. Ltd (131220) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for DAIHAN Scientific Co. Ltd (2012–2024)
Year-by-year debt coverage analysis for DAIHAN Scientific Co. Ltd. Check earnings quality score of DAIHAN Scientific Co. Ltd to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.16x | ₩3.99 Billion | ₩25.59 Billion | ▼ -19.4% |
| 2023 | 0.19x | ₩4.79 Billion | ₩24.80 Billion | ▼ -1.4% |
| 2022 | 0.20x | ₩4.51 Billion | ₩23.02 Billion | ▲ +5.8% |
| 2021 | 0.19x | ₩4.13 Billion | ₩22.29 Billion | ▼ -45.4% |
| 2020 | 0.34x | ₩5.35 Billion | ₩15.74 Billion | ▲ +125.6% |
| 2019 | 0.15x | ₩2.44 Billion | ₩16.20 Billion | ▼ -46.4% |
| 2018 | 0.28x | ₩3.76 Billion | ₩13.39 Billion | ▼ -21.0% |
| 2017 | 0.36x | ₩4.58 Billion | ₩12.89 Billion | ▲ +50.4% |
| 2016 | 0.24x | ₩4.12 Billion | ₩17.45 Billion | ▲ +361.2% |
| 2015 | 0.05x | ₩898.12 Million | ₩17.53 Billion | ▼ -63.1% |
| 2014 | 0.14x | ₩2.59 Billion | ₩18.66 Billion | ▲ +260.3% |
| 2012 | 0.04x | ₩565.94 Million | ₩14.69 Billion | — |